FMP1/AS02A

BIOLOGICAL2 trials

Sponsors

U.S. Army Medical Research and Development Command

Conditions

MalariaMalaria, Falciparum

Phase 1

Safety Study of Candidate Malaria Vaccine FMP1/AS02A in Healthy Adults in Bandiagara, Mali

CompletedNCT00308061

U.S. Army Medical Research and Development CommandMalaria

Start: 2003-07-31End: 2005-07-31Updated: 2017-07-31

Phase 2

Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine

CompletedNCT00223990

U.S. Army Medical Research and Development CommandMalaria, Falciparum

Start: 2005-04-08End: 2007-06-30Updated: 2021-02-12

Related Papers

Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya.

2009-03-05228 citations